Can I Take Singulair (Montelukast) While Pregnant?

Is Montelukast Safe to Take During Pregnancy?

If you're pregnant and taking montelukast (Singulair) for asthma or allergies, the honest answer is: it's not clearly harmful, but it's also not clearly proven safe. Available data have not shown a consistent pattern of birth defects, yet human research remains limited. What that means for you is that this is a conversation to have with your provider rather than a decision to make alone or by stopping abruptly.

Montelukast belongs to a drug class called leukotriene receptor antagonists (medications that block inflammatory chemicals that trigger asthma and allergy symptoms). Before the FDA retired its old pregnancy labeling system, montelukast held a Category B rating, meaning animal studies showed no harm but solid human data were still lacking. That middle-ground status still describes where the science sits today.

The tension at the heart of this question is real: untreated or poorly controlled asthma during pregnancy carries its own documented risks to the fetus, including low birth weight and preterm birth. Weighing medication uncertainty against disease risk is exactly why a personalized provider conversation matters so much here.

What Does the Research Actually Show?

Large observational studies, including data from the OTIS Collaborative Research Group (a network that tracks pregnancy medication outcomes), have not found a statistically significant increase in major malformations (serious structural birth defects) with first-trimester montelukast exposure. That is genuinely reassuring, though not a clean bill of health.

Important limits apply to those findings:

• No randomized controlled trials exist in pregnant populations, because enrolling pregnant people in drug trials is ethically complex.
• Many studies rely on voluntary reporting, which can miss cases and skew results.
• Sample sizes remain relatively small, making it harder to detect rare risks.

In 2021, the FDA issued a safety communication flagging neuropsychiatric side effects (mood changes, sleep disturbances, and in rare cases suicidal thinking) as a concern with montelukast use in general. That warning did not specifically address fetal neurological risk, so it should not be directly applied to pregnancy without guidance from your provider.

How Do the Options Compare?

Montelukast is rarely the first choice during pregnancy, mostly because better-studied options exist for both asthma and allergies. The table below summarizes the landscape.

If you are already stable on montelukast and switching mid-pregnancy would require a trial-and-error period that risks symptom flares, your provider may reasonably recommend staying the course.

Should You Stop Taking It the Moment You Find Out You're Pregnant?

Stopping without a plan is one of the most common and understandable instincts, and it can backfire. Here is why that matters:

• Asthma control affects fetal oxygen. A significant flare, especially one requiring emergency care, poses more immediate risk than the theoretical medication risk you're trying to avoid.
• Abrupt discontinuation destabilizes control faster than a thoughtful switch to a preferred alternative.
• Trimester matters. The first trimester, when organs are forming (a process called organogenesis), is the highest-scrutiny window. If you took montelukast before you knew you were pregnant, that retrospective exposure is generally considered lower concern than an active prospective decision to continue.

The right approach is to contact your OB-GYN or allergist promptly, bring your full medication list, and discuss whether to continue, switch, or taper. Do not decide alone.

What Is Probably Not Worth the Worry?

A few common reactions to this uncertainty tend to cause more problems than they solve.

Switching to herbal or supplement-based allergy remedies is a frequent impulse during pregnancy. These products are not better studied than montelukast, are not FDA-regulated for safety or efficacy, and some, such as high-dose herbal teas or botanical decongestants, carry their own documented concerns in pregnancy.

Stopping all allergy or asthma treatment entirely in an attempt to "play it safe" is a strategy that can escalate quickly. Worsening symptoms may require oral steroids or emergency intervention, both of which carry greater risks than a stable low-dose controller medication.

Relying on online forums for drug safety decisions is understandable when you are anxious and looking for community. However, anecdote and fear often outweigh actual pharmacovigilance data (the systematic tracking of medication side effects in real populations) in those spaces. Individual stories are not substitutes for provider guidance.

What to Bring to Your Next Appointment

A focused conversation with your provider is the most useful thing you can do. To make that conversation productive:

• Clarify your indication. Are you taking montelukast for asthma alone, allergic rhinitis alone, or both? The risk-benefit calculation differs by condition.
• Ask about trimester-specific guidance. Your provider may have different recommendations depending on how far along you are.
• Ask about pregnancy registries. Enrolling in a medication use-in-pregnancy registry helps fill the data gaps that currently limit confidence in safety conclusions, and your experience could help other pregnant patients in the future.
• Ask what to watch for. Knowing which symptoms warrant an urgent call gives you a clear action plan rather than ongoing ambient worry.

Doctronic, the first AI legally authorized to practice medicine, offers free AI consultations and $39 video visits available 24/7, so you can get structured guidance quickly if your next OB appointment is weeks away. With over 22 million AI consultations completed and 99.2% treatment plan alignment with board-certified physicians, it is a practical way to prepare for that conversation.

Frequently Asked Questions

Can montelukast cause birth defects?

Current observational studies have not found a statistically significant increase in major birth defects with montelukast use. However, human data remain limited, so a clear safety guarantee cannot be given. Discuss individual risk with your provider.

Is it safe to take Singulair in the first trimester?

The first trimester is the highest-scrutiny period because organs are forming. Available data have not shown a clear harm signal, but montelukast is not FDA-approved for pregnancy. A provider conversation before continuing is strongly recommended.

What is the best asthma medication for pregnancy?

Inhaled corticosteroids, particularly budesonide, are generally considered the preferred controller medication for asthma in pregnancy. They have a longer safety record and are better studied than most oral alternatives, including montelukast.

What happens if I accidentally took montelukast while pregnant?

Retrospective exposure before you knew you were pregnant is generally considered lower concern based on current data. Let your OB-GYN know so they can monitor appropriately and help you weigh next steps going forward.

Can untreated asthma harm my baby during pregnancy?

Yes. Poorly controlled asthma may reduce fetal oxygen supply and has been linked to low birth weight and preterm birth. Stopping asthma treatment without a replacement plan can introduce real risk to your pregnancy.

The Bottom Line

Whether to continue montelukast during pregnancy has no single universal answer. The risks of uncontrolled asthma matter just as much as medication risk, and abruptly stopping without a plan can backfire. Safer, better-studied options often exist, but switching mid-pregnancy carries its own considerations. The right path depends on your trimester, your indication, and how well your symptoms are controlled. Doctronic offers free AI consultations and affordable $39 video visits, available 24/7, to help you prepare an informed, structured conversation with a licensed clinician quickly. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.